Category: Health

CytoDyn Inc. (CYDY) Stock Price Today, Quote & News

CytoDyn is  a   biotech which has proved helpful hard but unsuccessfully to produce a single therapy, variously named Pro 140, leronlimab, as well as Vyrologix.

In development of this particular treatment, CytoDyn has cast its net wide and far both geographically and in phrases of possible indications.

CytoDyn’s inventories of leronlimab are building up, whether they’ll ever be used is an open question.

While CYDY  has been dawdling, market opportunities for leronlimab as being a combination therapy in the treatment of multi-drug-resistant HIV have been closing.

I am composing my fifteenth CytoDyn (OTCQB:CYDY) guide on FintechZoom to celebrate the sale made of my past several shares. My 1st CytoDyn post, “CytoDyn: What In order to Do When It’s Too Good In order to Be True?”, set out the following prediction:

Instead I expect it to be a serial disappointer. CEO Pourhassan offered such an extremely marketing image in the Uptick Newswire job interview that I came away with a poor opinion of the company.

Irony of irony, my bad impression of the business enterprise has grown steadily, though the disappointment has not been financial. 2 years ago CytoDyn was trading <$1.00. On 2/19/20 as I create, it trades during $5.26; the closing transaction of mine was on 2/11/21 > $6.00.

What manner of stock  is this that delivers a > six bagger yet still disappoints? Therein lies the story; allow me to explain.

CytoDyn acquired its much storied therapy (which I shall mean as leronlimab) back during 2012, announced as follows:

CytoDyn Inc…. has completed the acquisition of Pro 140, an experimental humanized monoclonal antibody (MAB) focusing on the CCR5 receptor for your therapy as well as avoidance of HIV, coming from Progenics Pharmaceuticals, Inc. of Tarrytown, NY. Pro 140 is a late Stage II clinical growth mAb with demonstrated anti-viral activity in HIV infected subjects. Today’s transaction of $3.5 million transfers ownership of this know-how and also connected intellectual property coming from Progenics to CytoDyn, and also roughly twenty five million mg of majority drug substance…. milestone payments after commencement of a stage III clinical trial ($1.5 million) as well as the first new drug program approval ($5 million), as well as royalty payments of 5 percent of net sales upon commercialization.

Since that point in time, CytoDyn’s helping nous, Nader Pourhassan [NP] has made this inauspicious acquisition into a springboard for CytoDyn to buy a market cap > $3.5 billion. It has done so in exclusive reliance on leronlimab.

 

Instead of having a pipeline with multiple indications and many therapies, it’s this single treatment as well as a “broad pipeline of indications” since it places it. I call certain pipelines, “pipedots.” In CytoDyn’s situation it touts the leronlimab of its as a likely beneficial therapy in dozens of indications.

The opening banner of its on the website of its (below) shows an energetic business with diverse interests albeit focused on leronlimab, several disease sorts, multiple publications in addition to multiple presentations.

Can it all be smoke and mirrors? That is a question I’ve been asking myself with the really beginning of the interest of mine in this organization. Judging by way of the multiples of thousands of several comments on listings accessible through Seeking Alpha’s CytoDyn Summary page, I’m much from alone in this particular question.

CytoDyn is a traditional battleground, or possibly some may say cult inventory. Its adherents are fiercely protective of its prospects, quick to label some negative opinions as scurrilous short mongering.

CytoDyn Inc. (CYDY) Stock Price Today, Quote & News

 

King Soopers is going to begin additional COVID 19 vaccinations

FintechZoom announced that King Soopers it is getting an additional supply of the Moderna COVID-19 vaccine together with the U.S. Federal Retail Pharmacy Program. The news will expand vaccination places to King Soopers as well as City Market Pharmacy locations statewide beginning Friday.

The vaccines will only be available to people that are presently eligible for inoculation.

Reservations are required for receiving a dose, and King Soopers asks to book a time slot on the internet at giving  

King Soopers in addition to the City Market have 147 drug stores across Colorado. They anticipate expanding vaccine distribution to the common public for the reason that the state government opens the vaccination program to various other groups.

Major pharmacies are coming out plans this week to get ready for the extra one million vaccine doses that have been promised by the White colored House.

And so far, over 32 million Americans have received one dose — 10 % of the country’s population. Of the weekend, more than four million vaccinations had been administered, a ramp set up out of previous days, based on the Centers for disease Control and Prevention.

The one million doses have been delivered to more than 6,500 locations together with the Federal Retail Policy program.

Walgreens told ABC News they will begin accepting appointments Tuesday and vaccinations in stores will begin as early on as Friday, prioritizing health care workers, people sixty five yrs of age and more mature, and people with preexisting conditions.

Still, Walgreen’s rollout is going to be slow, starting in only fifteen states and jurisdictions. Available meetings and vaccines are limited.

CVS said they will begin processing appointments Thursday with vaccines currently being administered as early on as Friday.

The participating pharmacies include:

-Walgreens (including Duane Reade)
-CVS Pharmacy, Inc. (including Long’s)
–Walmart, Inc. (including Sam’s Club)
-Rite Aid Corp.
-The Kroger Co. (including Kroger, Harris Teeter, Fred Meyer, Fry’s, Ralphs, King Soopers, Smiths, City Market, Dillons, Mariano’s, Pick-n-Save, Copps , Metro Market)
-Publix Super Markets, Inc.
-Costco Wholesale Corp.
-Albertsons Companies, Inc. (including Osco, Jewel Osco, Albertsons, Albertsons Market, Safeway, Tom Thumb, Star Market, Shaw’s, Haggen, Acme, Randalls, Carrs, Market Street, United, Vons, Pavilions, Amigos, Lucky’s, Pak n Save, Sav-On)
-Hy-Vee, Inc.
-Meijer Inc.

King Soopers will begin more COVID 19 vaccinations
-H-E-B, LP
-Retail Business Services, LLC (including Food Lion, Giant Food, The Giant Company, Hannaford Bros Co, Stop & Shop) -Winn-Dixie Stores Inc. (including Winn Dixie, Harveys, Fresco Y Mas)